Drug Patent Expirations for Mar 2 2013

If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations

FDA Orange Book archives from 2005 to present

Advertise
here

This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents





Drug Patent Expirations for March 2 2013

Tradename Applicant Generic Name Patent
Expiration
LUNESTA Sunovion Pharms Inc eszopiclone Mar 2, 2013
RECLAST Novartis zoledronic acid Mar 2, 2013
ZOMETA Novartis zoledronic acid Mar 2, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.



DrugPatentWatch
Infographics

Which pharmaceutical companies recieved the most drug approvals last
year

Which Companies had the Most Drug
Approvals Last Year?

More
infographics &raquo





DrugPatentWatch Serves Your Competitive Intelligence
Needs

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
    information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
    export
  • More…
See the Database
Preview
and Plan
Comparison
. Contact Us with any
questions.





The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.






Click here for reuse options!
Copyright 2013 Biotechblog

See you in Pittsburgh in Early April

I will be in Pittsburgh from April 4-5th to give  a talk at Carnegie Mellon’s business school, Tepper, and at the Innovation in Healthcare Technology Conference. I will be providing perspectives on changing dynamics in the biotechnology industry based on my work with the Journal of Commercial Biotechnology, and Scientific American Worldview, and my globalization research collected […]




Click here for reuse options!
Copyright 2013 Biotechblog

Access to Capital – The Answers are in the Crowd?

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. There is a saying that if you have a tough problem, you can find the solution if  you ask enough people – the answer is in the room.   […]




Click here for reuse options!
Copyright 2013 Biotechblog

A Long Road to an Informed Public Opinion

This guest post is from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. Bioethics in the public eye has been recognised as an integral part of modern biology research for a while […]




Click here for reuse options!
Copyright 2013 Biotechblog

New Emotional Analytics Provider, BehaviorMatrix, Conducts Largest…

Last week, at the 12th Annual ePharma Summit in New York City, Philadelphia based…(PRWeb March 13, 2013)Read the full story at http://www.prweb.com/releases/BehaviorMatrix/OncologyStudy/prweb10525610.htm




Click here for reuse options!
Copyright 2013 Biotechblog

Antiviral Therapeutics – Technologies, Markets and Companies – 2013

This antiviral therapeutics market research report is now available to purchase at Research and Markets. The report reviews…(PRWeb March 13, 2013)Read the full story at http://www.prweb.com/releases/2013/3/prweb10526473.htm




Click here for reuse options!
Copyright 2013 Biotechblog

Precision Motion Controller for Closed-Loop Positioning Systems…

PI (Physik Instrumente) LP offers a new closed-loop digital motion controller for precision positioning systems, model C-884.4D.(PRWeb March 13, 2013)Read the full story at http://www.prweb.com/releases/2013/3/prweb10525512.htm




Click here for reuse options!
Copyright 2013 Biotechblog

Washington State University to Present on Tin Nanoneedles: A…

Next Generation Batteries 2013 Advance Registration Expires this Friday, March 15th – Register now and Save $100

(PRWeb March 13, 2013)

Read the full story at http://www.prweb.com/releases/2013/3/prweb10524232.htm






Click here for reuse options!
Copyright 2013 Biotechblog

Positive Clinical Breast Cancer Data Presented for NuView’s Molecular…

Next generation PET imaging agent identifies 100% of malignant breast cancer tumors in clinical trial and displays potential to replace many invasive biopsy procedures.(PRWeb March 13, 2013)Read the full story at http://www.prweb.com/releases/2013/3…




Click here for reuse options!
Copyright 2013 Biotechblog

Black Mold Shuts Down Parts of Mason County Jail, My Cleaning Products…

Black mold was discovered in Mason County Jail. Stating that it could risk the health of anyone exposed to it, My Cleaning Products said that prompt mold remediation is needed and it recommended…(PRWeb March 13, 2013)Read the full story at http://…




Click here for reuse options!
Copyright 2013 Biotechblog

%d bloggers like this: